Equity Research, Broker Reports, and media content on Redx Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Redx Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Redx Pharma Plc

Company Profile

  • Personnel
  • James Mead, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Redx Pharma Plc. We currently have 101 research reports from 7 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 48.4/130p
  • Daily Volume: N/A
  • Daily Liquidity: (0.00%)
  • # Shares: 275.3m
  • Market Cap: £213.3m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
11Oct21 07:00 RNS Redx Pharma plc - R&D Day and New Clinical Data for ROCK2 Inhibitor
05Oct21 07:00 RNS Redx Pharma plc - Redx to host Virtual R&D Day on 11 October 2021
27Sep21 08:00 RNS Redx Pharma plc - Exercise of Options and Total Voting Rights
20Sep21 16:59 RNS Redx Pharma plc - Redx Presents Encouraging Phase 1 Data for RXC004
17Sep21 11:06 RNS Redx Pharma plc - Second Price Monitoring Extn
17Sep21 11:00 RNS Redx Pharma plc - Price Monitoring Extension
16Sep21 12:16 RNS Redx Pharma plc - Price Monitoring Extension
  • Frequency of research reports

     

  • Research reports on

    Redx Pharma Plc

  • Providers covering

    Redx Pharma Plc